A Higher Dose of Dasatinib May Increase the Possibility of Crossing the Blood–brain Barrier in the Treatment of Patients With Philadelphia Chromosome–positive Acute Lymphoblastic Leukemia
Xiaoyuan Gong, Le Li, Hui Wei, Bingcheng Liu, Chunlin Zhou, Guangji Zhang, Kaiqi Liu, Dong Lin, Benfa Gong, Shuning Wei, Yan Li, Yingchang Mi, Ying Wang, Jianxiang Wang
Topics & Concepts
MedicineDasatinibLymphoblastic LeukemiaPhiladelphia chromosomeBlood–brain barrierInternal medicineOncologyLeukemiaPharmacologyImatinibGeneticsChromosomal translocationGeneMyeloid leukemiaCentral nervous systemBiologyChronic Myeloid Leukemia TreatmentsAcute Lymphoblastic Leukemia researchChronic Lymphocytic Leukemia Research